Evidence map›Paper›PMID 42315808›Full record

ArticleJournal of cardiovascular translational research2026

Low-dose Empagliflozin Does Not Modify Myocardial Energetics and Function in a Large-animal Model of Hibernating Myocardium.

Danielle Medina-Hernández, Carlos Galán-Arriola, Pedro Luis Cepas, Daniel Pérez-Camargo, Laura Cádiz, Daniel Pereda, Javier Sánchez-González, Ana García-Alvarez, Borja Ibáñez

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of cardiovascular translational research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Danielle Medina-HernándezCentro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), C. de Melchor Fernández Almagro, 3, 28029, Madrid, Spain.
Carlos Galán-ArriolaCentro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), C. de Melchor Fernández Almagro, 3, 28029, Madrid, Spain.
Pedro Luis CepasCentro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), C. de Melchor Fernández Almagro, 3, 28029, Madrid, Spain.
Daniel Pérez-CamargoCardiac Surgery Department, Hospital Universitario Clínico San Carlos, Madrid, Spain.
Laura CádizCentro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), C. de Melchor Fernández Almagro, 3, 28029, Madrid, Spain.
Daniel PeredaCentro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), C. de Melchor Fernández Almagro, 3, 28029, Madrid, Spain.
Javier Sánchez-GonzálezClinical Science, Philips Healthcare Iberia, Madrid, Spain.
Ana García-AlvarezCentro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), C. de Melchor Fernández Almagro, 3, 28029, Madrid, Spain.
Borja IbáñezCentro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC), C. de Melchor Fernández Almagro, 3, 28029, Madrid, Spain. bibanez@cnic.es.ORCID http://orcid.org/0000-0002-5036-254X

Funding

Sociedad Española de Cardiologia Investigacion Basica 2021
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hibernating myocardiumIschemic heart diseaseLarge-animal modelSGLT2 inhibitors

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.